Your browser doesn't support javascript.
loading
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Vadrevu, Krishna Mohan; Ganneru, Brunda; Reddy, Siddharth; Jogdand, Harsh; Raju, Dugyala; Sapkal, Gajanan; Yadav, Pragya; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar Vivek; Gillurkar, Chandra Sekhar; Kushwaha, Jitendra Singh; Mohapatra, Satyajit; Bhate, Amit; Rai, Sanjay Kumar; Ella, Raches; Abraham, Priya; Prasad, Sai; Ella, Krishna.
Afiliação
  • Vadrevu KM; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India. kmohan@bharatbiotech.com.
  • Ganneru B; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
  • Reddy S; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
  • Jogdand H; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
  • Raju D; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
  • Sapkal G; Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Yadav P; Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Reddy P; Nizam's Institute of Medical Sciences, Hyderabad, India.
  • Verma S; Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India.
  • Singh C; All India Institute of Medical Sciences, Patna, India.
  • Redkar SV; Redkar Hospital, Dargalim, India.
  • Gillurkar CS; Gillurkar Hospital, Nagpur, India.
  • Kushwaha JS; Prakhar Hospital, Kanpur, India.
  • Mohapatra S; SRM Hospital and Research Centre, Kattankulathur, India.
  • Bhate A; Jeevan Rekha Hospital, Belgaum, India.
  • Rai SK; All India Institute of Medical Sciences, New Delhi, India.
  • Ella R; Independent Clinical Development Consultant, Cambridge, USA.
  • Abraham P; Indian Council of Medical Research-National Institute of Virology, Pune, India.
  • Prasad S; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
  • Ella K; Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, India.
Sci Rep ; 12(1): 12038, 2022 07 14.
Article em En | MEDLINE | ID: mdl-35835822
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunogenicidade da Vacina / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia